Sirolimus-Coated Balloon (SCB) - Nanolute Series
De novo lesions, In-Stent Restenosis (ISR), Small Vessel, Bifurcation
Commercial (Post-market)Completed Studies/Commercial
Key Facts
Indication
De novo lesions, In-Stent Restenosis (ISR), Small Vessel, Bifurcation
Phase
Commercial (Post-market)
Status
Completed Studies/Commercial
Company
About Concept Medical
Headquartered in Tampa, Florida, Concept Medical is a leader in developing innovative solutions for cardiovascular diseases, focusing on unmet clinical needs in coronary and peripheral artery disease. The company's mission, 'Converting Concepts into Reality,' is powered by its patented Nanolute, Nanoactive, and Envisolution technologies. With a vast clinical trial portfolio including the world's largest RCT on diabetic patients and multiple ongoing IDE studies in the US, Concept Medical is positioned at the forefront of the drug-coated balloon and stent market.
View full company profile